*仅供医学专业人士阅读参考
2022 CSCO前“研”速递,郭琤琤教授分享鬼臼毒素化疗药物治疗新进展。
参考文献:
[1]Clark PI,Slevin ML. The clinical pharmacology of etoposide and teniposide. Clin Pharmacokinet. 1987 Apr;12(4):223-52.
[2]Zhao W,Cong Y,Li HM,et al.Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy.Nat Prod Rep.2021 Mar 1;38(3):470-488.
[3]李岩,石蕊,陈建新,李珊,康勋,陈静,赵凯红,李文斌.VM-26和DDP联合化疗对复发高级别脑胶质瘤的治疗体会[J].首都医科大学学报,2015,36(05):786-790.
[4]陈青青,等.药物临床观察.2015;(7):788-791.
[5]Postmus PE,et al.J Clin Oncol.1995 Mar;13(3):660-5.
[6]Postmus PE,et al.Journal of Clinical Oncology 2000;18(19):3400–8.